We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
+1.58%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.12B
AUM Growth
-$199M
(-3.7%)
Cap. Flow
-$200M
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
24.54%
Holding
885
New
102
Increased
287
Reduced
309
Closed
94
Avg Time Held
1.8
years
Top 10 Avg Time Held
1.5
years
Top 20 Avg Time Held
1.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$25.9M |
| 2 |
Citizens Financial Group
CFG
|
+$23.8M |
| 3 |
EOG Resources
EOG
|
+$23.7M |
| 4 |
Independent Bank Group, Inc.
IBTX
|
+$18.4M |
| 5 |
Acuity Brands
AYI
|
+$17.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BEAV
B/E Aerospace Inc
BEAV
|
+$48.6M |
| 2 |
Ventas
VTR
|
+$42.2M |
| 3 |
Centene
CNC
|
+$38.9M |
| 4 |
Manhattan Associates
MANH
|
+$30.4M |
| 5 |
Salesforce
CRM
|
+$24.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.09% |
| 2 | Financials | 14.79% |
| 3 | Technology | 14.28% |
| 4 | Consumer Discretionary | 14.11% |
| 5 | Industrials | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
401
Kinder Morgan
KMI
$75.2B
| $635K | 0.01% |
30,671
+655
| +2% | +$13.8K |
2014 Q4
8 quarters
|
|
402
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.1B
| $634K | 0.01% |
3,209
+966
| +43% | +$182K |
2015 Q4
4 quarters
|
|
403
Nebius Group N.V.
NBIS
$46.3B
| $632K | 0.01% |
31,373
+528
| +2% | +$10.4K |
2016 Q2
2 quarters
|
|
404
iShares Gold Trust
IAU
$61.7B
| $626K | 0.01% |
+28,249
| New | +$663K |
2016 Q4
0 quarters
|
|
405
Eastman Chemical
EMN
$7.2B
| $623K | 0.01% |
8,288
-218
| -3% | -$15.7K |
2015 Q2
6 quarters
|
|
406
Vanguard Financials ETF
VFH
$13.1B
| $615K | 0.01% |
+10,370
| New | +$566K |
2016 Q4
0 quarters
|
|
407
Silicon Motion
SIMO
$7.32B
| $605K | 0.01% |
14,249
+48
| +0.3% | +$2.19K |
2015 Q1
7 quarters
|
|
408
DELISTED
KKR & Co. Inc. 6.75% Series A Preferred Units
KKR.PRA
| $603K | 0.01% |
23,853
| – | – |
2016 Q3
1 quarter
|
|
|
FRC.PRE.CL
409
DELISTED
First Republic Bank
FRC.PRE.CL
| $594K | 0.01% |
21,830
+5,166
| +31% | +$139K |
2016 Q2
2 quarters
|
|
410
Banco Macro
BMA
$4.08B
| $587K | 0.01% |
9,120
-198
| -2% | -$14.3K |
2015 Q1
7 quarters
|
|
411
CBRE Group
CBRE
$38.6B
| $587K | 0.01% |
18,645
-110
| -0.6% | -$3.18K |
2014 Q2
10 quarters
|
|
|
RDS.A
412
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $587K | 0.01% |
11,177
+928
| +9% | +$46.2K |
2014 Q1
11 quarters
|
|
413
Cummins
CMI
$74.1B
| $576K | 0.01% |
4,213
+70
| +2% | +$9.37K |
2015 Q2
6 quarters
|
|
414
iShares Russell 1000 Growth ETF
IWF
$125B
| $566K | 0.01% |
21,568
+2,852
| +15% | +$74K |
2015 Q2
6 quarters
|
|
415
Lockheed Martin
LMT
$126B
| $549K | 0.01% |
2,196
-89
| -4% | -$22.2K |
2013 Q2
14 quarters
|
|
416
Vanguard Morningstar Small-Cap Value ETF
VBR
$36B
| $544K | 0.01% |
4,494
-40
| -0.9% | -$4.59K |
2014 Q1
11 quarters
|
|
|
XL
417
DELISTED
XL Group Ltd.
XL
| $540K | 0.01% |
14,502
+1,002
| +7% | +$35.9K |
2016 Q1
3 quarters
|
|
|
PE
418
DELISTED
PARSLEY ENERGY INC
PE
| $539K | 0.01% |
+15,283
| New | +$541K |
2016 Q4
0 quarters
|
|
|
MSCC
419
DELISTED
Microsemi Corp
MSCC
| $535K | 0.01% |
+9,906
| New | +$484K |
2016 Q4
0 quarters
|
|
|
PETX
420
DELISTED
Aratana Therapeutics, Inc.
PETX
| $533K | 0.01% |
74,244
+3,206
| +5% | +$25.9K |
2014 Q4
8 quarters
|
|
421
State Street Technology Select Sector SPDR ETF
XLK
$122B
| $522K | 0.01% |
21,582
+1,928
| +10% | +$46K |
2014 Q1
11 quarters
|
|
422
Dentsply Sirona
XRAY
$1.72B
| $517K | 0.01% |
8,950
+495
| +6% | +$29.2K |
2016 Q3
1 quarter
|
|
423
iShares Dow Jones US ETF
IYY
$3.01B
| $514K | 0.01% |
9,166
+6
| +0.1% | +$329 |
2014 Q4
8 quarters
|
|
424
Oxford Square Capital
OXSQ
$143M
| $506K | 0.01% |
76,498
| – | – |
2013 Q3
13 quarters
|
|
425
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.2B
| $506K | 0.01% |
+12,422
| New | +$502K |
2016 Q4
0 quarters
|
|
Similar funds
CAM
DL
TCM
HCM
AL
AT
Geneva Advisors's Q4 2016 Portfolio in Review
As of Q4 2016, Geneva Advisors held 885 positions worth $5.12B, down 3.7% from $5.32B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Geneva Advisors withdrew a net $200M in Q4 2016, closing 94 positions and reducing 309 holdings. Its most notable exit was Ventas, an estimated $42.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
Against the trend, Geneva Advisors opened a new position in Citizens Financial Group worth $28M.
- Geneva Advisors's largest Q4 2016 buy was Citizens Financial Group: 786,703 shares worth $28M.
- Geneva Advisors added most to Celgene Corp in Q4 2016, an estimated $25.9M increase.
- Geneva Advisors's biggest Q4 2016 reduction was B/E Aerospace Inc, cutting an estimated $48.6M.
- Geneva Advisors fully exited Ventas in Q4 2016, selling an estimated $42.2M.
- Geneva Advisors's ten largest holdings make up 25% of its $5.12B portfolio in Q4 2016.
- Geneva Advisors opened 102 new positions and closed 94 in Q4 2016.
- Geneva Advisors's portfolio value fell 3.7% quarter-over-quarter to $5.12B.
Based on Geneva Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.